Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures.
The present study investigates the mechanisms involved in the anticonvulsant effect of melatonin in maximum electroshock (MES) seizures. Melatonin (25-100 mg/kg) dose-dependently decreased the duration of tonic hindlimb extension (THLE). The anticonvulsant effect of melatonin was blocked by bicuculline, a GABA(A) receptor antagonist, and luzindole, an ML(1) receptor antagonist, while prazosin, an ML(2) receptor antagonist, enhanced the anticonvulsant actions of melatonin in this seizure model. Administration of serotonergic agents, mianserin and ondansetron, along with melatonin, increased the antiseizurogenic activity of melatonin, while buspirone had no effect. Pretreating the animals with diazepam, carbamazepine or lamotrigine enhanced the anticonvulsant effect of melatonin. Melatonin thus appears to be an effective anticonvulsant, and melatonin ML(1) receptors, GABAergic and serotonergic mechanisms may play an important role in mediating the anticonvulsant activity of melatonin in electroshock seizures.
Ray
M
M
Department of Pharmacology, University College of Medical Sciences and GTB Hospital, Delhi, India.
Mediratta
P K
PK
Reeta
Kh
Kh
Mahajan
P
P
Sharma
K K
KK
D000818:Animals; D000927:Anticonvulsants / Q000378:metabolism / Q000627:therapeutic use*; D004597:Electroshock / Q000379:methods*; D058785:GABA-A Receptor Agonists; D008297:Male; D008550:Melatonin / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice; D011963:Receptors, GABA-A / Q000502:physiology; D044094:Receptors, Melatonin / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D011985:Receptors, Serotonin / Q000502:physiology; D012640:Seizures / Q000188:drug therapy* / Q000378:metabolism
D000927:Anticonvulsants; D058785:GABA-A Receptor Agonists; D011963:Receptors, GABA-A; D044094:Receptors, Melatonin; D011985:Receptors, Serotonin; D008550:Melatonin